Systematic ReviewResearchMedication SafetyNew Grad Friendly

Normal device readings did not exclude rare structural complications after left bundle pacing

Heart rhythm (PubMed)Aug 23, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review of case-based evidence grouped rare left bundle branch area pacing complications into five clinical categories and cautioned that normal device parameters do not exclude structural injury.

What NurseJet pulled from the source

Sixty-seven case reports or small case series described septal, vascular, valvular or subvalvular, mechanical or lead-related, and electrophysiologic complications. Presentations included delayed perforation, arrhythmias, thromboembolism, tamponade, vascular injury that mimicked acute coronary syndromes, and other structural problems despite normal electrical measurements.

Why this matters for nurses

Telemetry and cardiac nurses may be first to recognize a new symptom after conduction-system pacing. The review emphasizes combining the patient’s presentation with rhythm, device data, and ordered imaging rather than using normal device measurements as the sole reassurance.

Bedside takeaway

Treat new symptoms after left bundle pacing as clinically meaningful even when device measurements appear normal.

How This Applies in Practice

Use this when: Monitoring a patient after left bundle branch area pacemaker implantation or evaluating a new post-procedure concern.

On your shift

Review the procedure timing, current symptoms, hemodynamics, rhythm, and available device data together.
Report new arrhythmia, instability, ischemia-like symptoms, or neurologic change through the urgent escalation pathway.
Prepare for ordered device interrogation and imaging without treating normal electrical parameters as a structural rule-out.

Keep in mind: Case-based evidence cannot quantify risk. Follow the cardiac team’s plan, facility protocol, and provider orders.

Key takeaways

The review synthesized 67 case reports or small case series rather than comparative trials.
Complications fell into septal, vascular, valvular or subvalvular, mechanical or lead-related, and electrophysiologic categories.
Delayed perforation could present with arrhythmia, thromboembolism, or tamponade.
Normal electrical device parameters did not rule out clinically important structural complications.

Practice implications

After left bundle branch area pacing, connect new hemodynamic change, arrhythmia, ischemia-like symptoms, or neurologic concern with the recent procedure and escalate promptly. Continue ordered rhythm and device monitoring while the team evaluates for structural as well as electrical causes.

Limitations & cautions

The evidence consists of case reports and small case series, which cannot estimate complication incidence or compare management strategies. Publication bias likely favors unusual or severe events.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Heart rhythm (PubMed)

Heart rhythm (PubMed). Rare Complications of Left Bundle Branch Area Pacing: A Systematic Review of Case-Based Evidence.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42633831/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

European heart journal (PubMed)Sep 6, 2026Research Article

In the pragmatic TARGET-D randomized trial, vitamin D dosing titrated to a serum target did not significantly reduce the composite of death, recurrent myocardial infarction, heart-failure hospitalization, or stroke after myocardial infarction.

Telemetry Med-SurgAI summaryReview source

Research ArticleResearchMedication SafetyPatient EducationAI summary · original source linked below

Among 630 participants followed for an average of 4.2 years, major cardiovascular events occurred in 15.7% with targeted vitamin D management and 18.4% with usual care (hazard ratio 0.85, 95% CI 0.58 to 1.24; P=0.40).

Key takeaways

At baseline, 87% of participants had a 25-hydroxyvitamin D level of 40 ng/mL or lower.
The primary composite outcome and the individual outcomes of death, heart-failure hospitalization, and stroke were not significantly different.
A lower recurrent-MI rate was a secondary finding and should not override the nonsignificant primary result.

Why this matters on shift

The trial cautions against presenting targeted vitamin D supplementation as a proven strategy for reducing major cardiovascular events after myocardial infarction.

Bedside takeaway

Present vitamin D as prescribed supplementation, not as a replacement for established post-MI secondary prevention.

Nursing implications

Reinforce the prescribed secondary-prevention plan and avoid implying that vitamin D replaces therapies with established post-MI benefit.

Limitations & cautions

Abstract-only summary. The trial included 630 participants, 78.1% were men, the primary confidence interval included benefit and no benefit, and individual secondary outcomes were not the primary endpoint.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

European heart journal (PubMed). Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of neurology (PubMed)Sep 6, 2026Systematic Review

A cumulative meta-analysis found longer survival over time in Duchenne muscular dystrophy, alongside a shift from predominantly respiratory toward cardiac causes of death.

Peds ICUAI summaryReview source

Systematic ReviewResearchPatient EducationAI summary · original source linked below

The review included 53 studies and more than 13,000 patients. Pooled median survival was 29 years among ventilated patients and 19 years among non-ventilated patients, but these study-level observational comparisons do not establish that ventilation alone caused the difference.

Key takeaways

Sixty percent of patients in the included studies received home mechanical ventilation.
Survival improved progressively over time in both ventilated and non-ventilated groups.
As respiratory survival improved, cardiac and other causes accounted for a larger share of deaths.

Why this matters on shift

Patients living longer with Duchenne muscular dystrophy may need sustained respiratory support plus ongoing cardiac and multisystem surveillance across care transitions.

Bedside takeaway

Verify each patient's established respiratory and cardiac plan during admissions and care transitions.

Nursing implications

During admissions and handoffs, verify the established ventilation, airway-clearance, and cardiac-monitoring plan and coordinate concerns with the multidisciplinary team.

Limitations & cautions

Abstract-only summary. This was a study-level meta-analysis of heterogeneous observational survival reports; the ventilated and non-ventilated groups were not randomized, so associations should not be interpreted as treatment effects.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of neurology (PubMed). Improving survival in Duchenne muscular dystrophy across eras: a systematic review and cumulative meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Heart rhythm (PubMed)Sep 4, 2026Clinical Guideline

A 2026 HRS/PACES scientific statement offers evidence-informed practical advice for antiarrhythmic use in clinical scenarios underrepresented in trials.

Telemetry Med-SurgAI summaryReview source

Clinical GuidelineGuidelineMedication SafetyAI summary · original source linked below

The statement identifies common scenarios in which antiarrhythmic-drug evidence and guidance are limited, then explains the rationale for recommendations using available evidence and expert clinical proficiency.

Key takeaways

The document focuses on scenarios that are not well represented in antiarrhythmic-drug trials.
Its practical advice combines the available evidence with multidisciplinary expert experience.
The abstract does not support applying one antiarrhythmic approach across all understudied situations.

Why this matters on shift

Antiarrhythmics can require close rhythm, hemodynamic, and adverse-effect surveillance in patients whose circumstances fall outside typical trial populations.

Bedside takeaway

Verify the scenario-specific treatment and monitoring plan, then follow provider orders and local medication-safety protocols.

Nursing implications

Verify the scenario-specific treatment and monitoring plan, then follow provider orders and local medication-safety protocols.

Limitations & cautions

Abstract-only summary. The abstract does not enumerate individual recommendations, patient groups, drug choices, doses, or monitoring thresholds.
AI-summarized from the linked source. Review the original statement before applying to practice.

Citations · exact source links

Heart rhythm (PubMed). 2026 HRS/PACES scientific statement on the use of antiarrhythmic drugs in understudied clinical scenarios.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Targeted vitamin D did not significantly reduce major cardiovascular events after MI

Duchenne survival has improved as respiratory and cardiac care evolved

HRS and PACES address antiarrhythmic use in understudied clinical scenarios